Teva Pharmaceutical Industries (TEVA) Treasury Shares (2009 - 2026)

Teva Pharmaceutical Industries (TEVA) has reported Treasury Shares for 18 consecutive years, with $4.1 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Treasury Shares changed 0.0% year-over-year to $4.1 billion; the trailing twelve-month figure through Jun 2026 stood at $4.1 billion (changed 0.0% YoY), and the FY2025 full-year result was $4.1 billion, changed 0.0% from the prior year.
• Treasury Shares steadied at $4.1 billion in Q2 2026 per TEVA's latest filing, from $4.1 billion in the prior quarter.
• Across five years, Treasury Shares topped out at $107.0 million in Q4 2024 and bottomed at $106.0 million in Q1 2022.
• Historically, Treasury Shares has averaged $106.2 million across 5 years, with a median of $106.0 million in 2022.
• The widest YoY moves for Treasury Shares: up 0.0% in 2022, down 0.0% in 2022.
• Over 5 years, Treasury Shares stood at $4.1 billion in 2022, then changed by 0.0% to $4.1 billion in 2023, then changed by 0.0% to $4.1 billion in 2024, then changed by 0.0% to $4.1 billion in 2025, then changed by 0.0% to $4.1 billion in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $4.1 billion, $4.1 billion, and $4.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.